← Back to Search

Hormone Therapy

Growth Hormone for Traumatic Brain Injury

Phase < 1
Waitlist Available
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

The purpose of this study is to look at the relationship between growth hormones, and recovery from a TBI - traumatic brain injury. It is believed that a TBI may interfere with the body's ability to produce growth hormones. These hormones may be needed by the body for growth, mental development and sexual maturation.

Eligible Conditions
  • Traumatic Brain Injury

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Neurocognitive changes following moderate/severe TBI

Trial Design

1Treatment groups
Experimental Treatment
Group I: Growth HormoneExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Somatotropin
FDA approved

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityOTHER
696 Previous Clinical Trials
22,885,086 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,694 Previous Clinical Trials
6,952,497 Total Patients Enrolled
University of VirginiaLead Sponsor
753 Previous Clinical Trials
1,245,023 Total Patients Enrolled

Frequently Asked Questions

~0 spots leftby Apr 2025